250 related articles for article (PubMed ID: 30413951)
1. Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.
Quattrocchi CC; Ramalho J; van der Molen AJ; Rovira À; Radbruch A;
Eur Radiol; 2019 Aug; 29(8):3959-3967. PubMed ID: 30413951
[TBL] [Abstract][Full Text] [Related]
2. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
[TBL] [Abstract][Full Text] [Related]
4. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
5. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
[TBL] [Abstract][Full Text] [Related]
7. Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.
Barisano G; Bigjahan B; Metting S; Cen S; Amezcua L; Lerner A; Toga AW; Law M
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1274-1281. PubMed ID: 31345942
[TBL] [Abstract][Full Text] [Related]
8. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
Flood TF; Stence NV; Maloney JA; Mirsky DM
Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Brain: Gadolinium Deposition in Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images Is Dependent on the Type of Contrast Agent.
Ryu YJ; Choi YH; Cheon JE; Lee WJ; Park S; Park JE; Kim WS; Kim IO
Invest Radiol; 2018 Apr; 53(4):246-255. PubMed ID: 29300210
[TBL] [Abstract][Full Text] [Related]
11. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population.
Renz DM; Kümpel S; Böttcher J; Pfeil A; Streitparth F; Waginger M; Reichenbach JR; Teichgräber UK; Mentzel HJ
Invest Radiol; 2018 Feb; 53(2):119-127. PubMed ID: 28976476
[TBL] [Abstract][Full Text] [Related]
13. No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents.
Radbruch A; Haase R; Kieslich PJ; Weberling LD; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Radiology; 2017 Mar; 282(3):699-707. PubMed ID: 27925871
[TBL] [Abstract][Full Text] [Related]
14. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
[TBL] [Abstract][Full Text] [Related]
15. The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.
Olchowy C; Cebulski K; Łasecki M; Chaber R; Olchowy A; Kałwak K; Zaleska-Dorobisz U
PLoS One; 2017; 12(2):e0171704. PubMed ID: 28187173
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents.
Kang H; Hii M; Le M; Tam R; Riddehough A; Traboulsee A; Kolind S; Freedman MS; Li DKB
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1597-1603. PubMed ID: 30139752
[TBL] [Abstract][Full Text] [Related]
18. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
[TBL] [Abstract][Full Text] [Related]
19. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
Cao Y; Huang DQ; Shih G; Prince MR
AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
[TBL] [Abstract][Full Text] [Related]
20. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
